In an early test case for copyright holders bringing claims related to content used to train artificial intelligence, a ...

Adial Pharmaceuticals (ADIL) announced patent number 12,226,401 was issued on February 18, 2025 by the United States Patent and Trademark ...

Milestone’s NDA for CARDAMYST is currently under review at the FDA with a Prescription Drug User Fee Act (PDUFA) target date of March 27, 2025. The Company continues to advance commercial preparations ...

The final year of Director Vidal’s tenure as the Director of the U.S. Patent and Trademark Office was a busy year for rulemaking at the Office.

United States patent number 6,469 is for "buoying vessels over shoals." Granted on May 22, 1849, the concept involves equipping large boats with "india-rubber cloth, or another suitable waterproof ...

Fudan University has disclosed phosphatidylcholine:ceramide cholinephosphotransferase 2 (SGMS2; SMS2) inhibitors reported to be useful for the treatment of cancer, atherosclerosis, dry eye, pulmonary ...

After three months in the role, Ruben Amorim's tenure at Man Utd has been a difficult one. The stats point to poor attacking numbers - but can they get a boost at Spurs? Adam Bate examines the ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.

The patent application No. 17/309,952 entitled “An A3 adenosine receptor ligand for use for achieving a fat loss effect”, has been accepted by the US Patent Office, will be issued on February ...

S&P 500 Today: Apple Gains on AI News While Powell’s Rate Stance Dampens Market Sentiment35 minutes ago U.S. Dollar Pulls Back As Traders Focus On Powell’s Testimony: Analysis For EUR/USD, GBP ...